Live ClinicalTrials.gov oncology trial comparison around an asset, plus landscapes and CI briefings.
Maintain this server? Claim it
Call this server's tools from your browser. Nothing to install.
Requests go through mcptry because browsers can't call most MCP servers directly. Header values are sent to the server for that request only and are never stored or logged.
Tool list from our last check. Connect live to refresh it.
Up to three interventional ClinicalTrials.gov studies matching an asset or target AND an oncology indication, side by side: sponsor, phase, status, declared arms, primary outcomes, last update, registry URL. Active studies first, then later phase; different sponsors where possible. Use a target (e.g. "KIF18A", "B7-H3") rather than one drug name to see other programmes.
Public asset or target, e.g. "sotorasib", "KRAS G12C", "B7-H3".
Oncology indication, e.g. "colorectal cancer", "NSCLC".
Up to three interventional ClinicalTrials.gov studies matching an asset or target AND an oncology indication, side by side: sponsor, phase, status, declared arms, primary outcomes, last update, registry URL. Active studies first, then later phase; different sponsors where possible. Use a target (e.g. "KIF18A", "B7-H3") rather than one drug name to see other programmes.
| Argument | Type | Description |
|---|---|---|
| asset* | string | Public asset or target, e.g. "sotorasib", "KRAS G12C", "B7-H3". |
| indication* | string | Oncology indication, e.g. "colorectal cancer", "NSCLC". |
{
"type": "object",
"required": [
"asset",
"indication"
],
"properties": {
"asset": {
"type": "string",
"maxLength": 80,
"description": "Public asset or target, e.g. \"sotorasib\", \"KRAS G12C\", \"B7-H3\"."
},
"indication": {
"type": "string",
"maxLength": 80,
"description": "Oncology indication, e.g. \"colorectal cancer\", \"NSCLC\"."
}
},
"additionalProperties": false
}Prognyx oncology competitive-intelligence briefings (each claim linked to a primary source) matching a drug, company, target or indication, newest first, with URL, date and summary.
| Argument | Type | Description |
|---|---|---|
| limit | integer | Briefings to return. |
| query | string | Drug, company, target or indication. Empty returns the latest. |
{
"type": "object",
"properties": {
"limit": {
"type": "integer",
"default": 5,
"maximum": 20,
"minimum": 1,
"description": "Briefings to return."
},
"query": {
"type": "string",
"maxLength": 120,
"description": "Drug, company, target or indication. Empty returns the latest."
}
},
"additionalProperties": false
}Live landscape for a target, asset, company, indication or NCT number: total and active study counts, leading sponsors, phase mix, the most recently updated studies with URLs, and related Prognyx briefings. Counts for phases and sponsors come from a recent sample, stated in the result.
| Argument | Type | Description |
|---|---|---|
| limit | integer | Studies to return. |
| query* | string | e.g. "KRAS G12C", "Nuvalent", "claudin 18.2 gastric cancer", "NCT05132075". |
{
"type": "object",
"required": [
"query"
],
"properties": {
"limit": {
"type": "integer",
"default": 10,
"maximum": 25,
"minimum": 1,
"description": "Studies to return."
},
"query": {
"type": "string",
"maxLength": 160,
"description": "e.g. \"KRAS G12C\", \"Nuvalent\", \"claudin 18.2 gastric cancer\", \"NCT05132075\"."
}
},
"additionalProperties": false
}